L’Institut de Biologie et Chimie des Proteines (IBCP), a principal research institute based in Lyon, France, has selected E-WorkBook Suite from IDBS to manage its research data and knowledge in developing nanoparticles for the treatment of viral infections.
Partnering with leading French and EU research organisations and universities, IBCP is advancing research into the creation of vaccines using nanoparticles made of polylactic acid (PLA), in sizes ranging from 150nm to 400nm, which can emulate the actions of antigens and create a new generation of targeted therapeutics. The biological application of nanoparticles is an area of nanotechnology that is rapidly developing, and it raises new possibilities in the diagnosis and treatment of HIV, Anthrax and FIV (Feline Immunodeficiency Virus).
By using all aspects of E-WorkBook, scientists at IBCP can benefit from a flexible framework to capture, analyse, and manage their experimental data in an efficient and compliant way. The solution’s extensive searching and reporting capabilities will accelerate their pace of research, and maximise the quality and re-use of their data. IBCP is provided with an application that will streamline workflow, accelerate discovery research, and improve productivity, while ensuring quality control for standard operating procedures (SOPs) and protecting Intellectual Property (IP).
'I was impressed with the quality of results E-WorkBook produced for our colleagues from CEA (Fontenay-aux-Roses, France), and therefore it was the natural choice for our laboratory,' said Professor Bernard Verrier, senior scientist at IBCP. 'Using E-WorkBook we will have a clearer picture of the research going on in our lab, improving the quality and quantity of reports and scientific papers, and enabling better interpretation of results. Using this solution to manage our data will save us several months of work, preventing duplication of experiments and ensuring that new users to the system have a comprehensive view of all data.'
